Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Annals of Epidemiology
|
July 15, 2010
Does ignoring model selection when assessing the effect of particulate matter air pollution on mortality make us too vigilant?
Steven Roberts, Michael A Martin
Science Translational Medicine
|
October 27, 2021
Comment on "Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2"
Michael A Martin, Katia Koelle
Environmental Research
|
March 17, 2007
A distributed lag approach to fitting non-linear dose-response models in particulate matter air pollution time series investigations
Steven Roberts, Michael A Martin
Environmental Health Perspectives
|
January 9, 2010
Bootstrap-after-bootstrap model averaging for reducing model uncertainty in model selection for air pollution mortality studies
Steven Roberts, Michael A Martin
Journal of Exposure Science & Environmental Epidemiology
|
August 18, 2005
Bootstrap model averaging in time series studies of particulate matter air pollution and mortality
Michael A Martin, Steven Roberts
American Journal of Epidemiology
|
September 29, 2006
The question of nonlinearity in the dose-response relation between particulate matter air pollution and mortality: can Akaike's Information Criterion be trusted to take the right turn?
Steven Roberts, Michael A Martin
Journal of Toxicology and Environmental Health. Part A
|
March 17, 2007
Methods for bias reduction in time-series studies of particulate matter air pollution and mortality
Steven Roberts, Michael A Martin
American Journal of Epidemiology
|
April 18, 2008
A regression approach for estimating multiday adverse health effects of PM10 when daily PM10 data are unavailable
Michael A Martin, Steven Roberts
Environmental Health Perspectives
|
December 23, 2006
Using supervised principal components analysis to assess multiple pollutant effects
Steven Roberts, Michael A Martin
Pharmacotherapy
|
May 8, 2013
Abacavir pharmacogenetics--from initial reports to standard of care
Michael A Martin, Deanna L Kroetz
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Annals of Epidemiology
|
July 15, 2010
Does ignoring model selection when assessing the effect of particulate matter air pollution on mortality make us too vigilant?
Steven Roberts, Michael A Martin
Science Translational Medicine
|
October 27, 2021
Comment on "Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2"
Michael A Martin, Katia Koelle
Environmental Research
|
March 17, 2007
A distributed lag approach to fitting non-linear dose-response models in particulate matter air pollution time series investigations
Steven Roberts, Michael A Martin
Environmental Health Perspectives
|
January 9, 2010
Bootstrap-after-bootstrap model averaging for reducing model uncertainty in model selection for air pollution mortality studies
Steven Roberts, Michael A Martin
Journal of Exposure Science & Environmental Epidemiology
|
August 18, 2005
Bootstrap model averaging in time series studies of particulate matter air pollution and mortality
Michael A Martin, Steven Roberts
American Journal of Epidemiology
|
September 29, 2006
The question of nonlinearity in the dose-response relation between particulate matter air pollution and mortality: can Akaike's Information Criterion be trusted to take the right turn?
Steven Roberts, Michael A Martin
Journal of Toxicology and Environmental Health. Part A
|
March 17, 2007
Methods for bias reduction in time-series studies of particulate matter air pollution and mortality
Steven Roberts, Michael A Martin
American Journal of Epidemiology
|
April 18, 2008
A regression approach for estimating multiday adverse health effects of PM10 when daily PM10 data are unavailable
Michael A Martin, Steven Roberts
Environmental Health Perspectives
|
December 23, 2006
Using supervised principal components analysis to assess multiple pollutant effects
Steven Roberts, Michael A Martin
Pharmacotherapy
|
May 8, 2013
Abacavir pharmacogenetics--from initial reports to standard of care
Michael A Martin, Deanna L Kroetz
Page
of 4